HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brenda Banwell Selected Research

Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)

11/2020Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS.
1/2018MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
1/2018Pediatric Multiple Sclerosis: an Update.
11/2013Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
7/2012Autoantibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in paediatric CNS demyelination: Recent developments and future directions.
4/2007Guidelines on the use of intravenous immune globulin for neurologic conditions.
2/2007Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brenda Banwell Research Topics

Disease

50Multiple Sclerosis
10/2022 - 03/2005
20Demyelinating Diseases (Demyelinating Disease)
01/2022 - 02/2007
14Neuromyelitis Optica (Devic's Disease)
01/2022 - 06/2009
7Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
11/2020 - 02/2007
5Optic Neuritis (Retrobulbar Neuritis)
05/2022 - 06/2009
5Infections
01/2021 - 05/2011
3Ganglion Cysts (Ganglion)
05/2022 - 12/2014
3Disease Progression
11/2021 - 10/2010
3Seizures (Absence Seizure)
10/2018 - 01/2010
3Brain Diseases (Brain Disorder)
10/2018 - 06/2009
3Encephalitis (Encephalitis, Rasmussen)
07/2014 - 04/2007
2COVID-19
04/2022 - 11/2021
2Fatigue
01/2022 - 01/2019
2Cognitive Dysfunction
11/2021 - 10/2010
2Atrophy
11/2021 - 01/2020
2Muscle Weakness
10/2021 - 03/2009
2Muscular Diseases (Myopathy)
10/2021 - 11/2017
2Myelitis
10/2021 - 08/2016
2Central Nervous System Diseases (CNS Diseases)
07/2014 - 10/2013
2Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
07/2014 - 04/2007
2Guillain-Barre Syndrome
06/2014 - 04/2007
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
06/2010 - 03/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2009 - 11/2006
2GM2 Gangliosidoses (GM2 Gangliosidosis)
08/2009 - 11/2006
2Alexander Disease (Alexander's Disease)
03/2005 - 03/2005
1Nasopharyngitis
12/2021
1Alopecia (Baldness)
12/2021
1Pancreatitis
12/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2021
1Abdominal Pain (Pain, Abdominal)
12/2021
1Rhabdomyolysis
10/2021
1Myalgia
10/2021
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
01/2021
1Psychotic Disorders (Schizoaffective Disorder)
11/2020
1Weight Loss (Weight Reduction)
01/2019
1Cytokine Release Syndrome
10/2018
1Leukopenia
01/2018
1Body Weight (Weight, Body)
01/2018
1Supraventricular Tachycardia
01/2018
1Congenital Structural Myopathies (Centronuclear Myopathy)
11/2017
1Central Core Myopathy (Central Core Disease)
11/2017
1Malignant Hyperthermia
11/2017
1Diffuse Brain Injuries (Diffuse Brain Injury)
07/2015
1Central Nervous System Lupus Vasculitis
07/2014
1Neuroinflammatory Diseases
07/2014
1Relapsing-Remitting Multiple Sclerosis
11/2013
1Microcephaly
10/2013
1Central Nervous System Vasculitis
11/2012

Drug/Important Bio-Agent (IBA)

12AntibodiesIBA
01/2022 - 04/2004
11Myelin-Oligodendrocyte GlycoproteinIBA
10/2022 - 07/2012
10Biological ProductsIBA
01/2021 - 04/2007
6Immunoglobulin G (IgG)IBA
10/2022 - 04/2004
6InterferonsIBA
01/2022 - 07/2013
5Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 01/2018
5AutoantibodiesIBA
11/2020 - 02/2007
4Biomarkers (Surrogate Marker)IBA
10/2018 - 06/2009
4AntigensIBA
11/2013 - 04/2004
3Retinaldehyde (Retinal)IBA
05/2022 - 12/2014
3AdipokinesIBA
01/2022 - 01/2019
3Creatine Kinase (Creatine Phosphokinase)IBA
12/2021 - 03/2009
3Rituximab (Mabthera)FDA Link
10/2021 - 07/2014
3EpitopesIBA
12/2014 - 01/2008
2Pharmaceutical PreparationsIBA
12/2021 - 08/2009
2EnzymesIBA
12/2021 - 10/2021
2anti-aquaporin 4 autoantibodyIBA
10/2021 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2005
2Interferon beta-1aFDA Link
01/2018 - 07/2013
2Protons (Proton)IBA
07/2015 - 05/2013
2Proteins (Proteins, Gene)FDA Link
09/2014 - 01/2008
2Peptides (Polypeptides)IBA
11/2013 - 02/2007
2Oligoclonal BandsIBA
05/2011 - 06/2009
2Vitamin DFDA LinkGeneric
05/2011 - 02/2011
2G(M2) Ganglioside (Ganglioside GM2)IBA
08/2009 - 11/2006
2beta-N-AcetylhexosaminidasesIBA
08/2009 - 11/2006
1VaccinesIBA
04/2022
1COVID-19 VaccinesIBA
04/2022
1teriflunomideIBA
12/2021
1Protein Isoforms (Isoforms)IBA
10/2021
1AdiponectinIBA
10/2021
1ImmunosorbentsIBA
10/2021
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2021
1GadoliniumIBA
01/2020
1SmokeIBA
01/2019
1tisagenlecleucelIBA
10/2018
1CytokinesIBA
10/2018
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2017
1SteroidsIBA
06/2015
1Potassium Channels (Potassium Channel)IBA
09/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2014
1Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA
10/2013
1Infliximab (Remicade)FDA Link
11/2012

Therapy/Procedure

18Therapeutics
04/2022 - 05/2005
3Immunomodulation
01/2020 - 03/2005
1Continuity of Patient Care
04/2022
1Ketogenic Diet
01/2022
1Off-Label Use
11/2021
1Injections
11/2021
1Duration of Therapy
10/2021
1Immunotherapy
01/2019
1Plasma Exchange
06/2015